SCOPUS 정보 검색 플랫폼

Journal of the Royal Society of Medicine

Volumn 97, Issue 9, 2004, Pages 440-441

Uveitis in a patient receiving rifabutin for Crohn's disease

(5) Awotesu, O a Missotten, T b Pitcher, M C c Lynn, W A d Lightman, S e

a QUEEN MARY UNIVERSITY OF LONDON (United Kingdom)

b MOORFIELDS EYE HOSPITAL (United Kingdom)

c NORTHWICK PARK HOSPITAL (United Kingdom)

d EALING HOSPITAL (United Kingdom)

e UNIVERSITY COLLEGE LONDON (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CLARITHROMYCIN; RIFABUTIN; STEROID;

ADULT; ARTICLE; CASE REPORT; CROHN DISEASE; DRUG INDUCED DISEASE; FEMALE; HUMAN; ILEOSTOMY; RECTUM RESECTION; STEROID THERAPY; UVEITIS; VISUAL ACUITY;

EID: 4644327949 PISSN: 01410768 EISSN: None Source Type: Journal
DOI: 10.1258/jrsm.97.9.440 Document Type: Article

Times cited : (12)

References (6)

1
- 0036190153
- Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease
- Shafran I, Kugler L, El-Zaatari FA, Naser SA, Sandoval J. Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease. Dig Liver Dis 2002;34:22-8
- (2002) Dig Liver Dis , vol.34 , pp. 22-28
- Shafran, I.¹ Kugler, L.² El-Zaatari, F.A.³ Naser, S.A.⁴ Sandoval, J.⁵

2
- 0030906446
- Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics
- Gui GP, Thomas PR, Tizard ML, et al. Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics. Antimicrob Chemother 1997;39:393-400
- (1997) Antimicrob Chemother , vol.39 , pp. 393-400
- Gui, G.P.¹ Thomas, P.R.² Tizard, M.L.³

3
- 17344366230
- Determinants of rifabutin-associated uveitis in patients treated with rifabutin, clarithromycin, and ethambutol for Mycobacterium avium complex bacteremia: A multivariate analysis
- Canadian HIV Trials Network Protocol 010 Study Group
- Shafran SD, Singer J, Zarowny DP, et al. Determinants of rifabutin-associated uveitis in patients treated with rifabutin, clarithromycin, and ethambutol for Mycobacterium avium complex bacteremia: a multivariate analysis. Canadian HIV Trials Network Protocol 010 Study Group. J Inject Dis 1998;177:252-5
- (1998) J Inject Dis , vol.177 , pp. 252-255
- Shafran, S.D.¹ Singer, J.² Zarowny, D.P.³

4
- 0030938674
- New ophthalmic manifestations of presumed rifabutin-related uveitis
- Arevalo JF, Russack V, Freeman WR. New ophthalmic manifestations of presumed rifabutin-related uveitis. Ophthalmic Surg Lasers 1997;28:321-4
- (1997) Ophthalmic Surg Lasers , vol.28 , pp. 321-324
- Arevalo, J.F.¹ Russack, V.² Freeman, W.R.³

5
- 0035084678
- Rifabutin-associated hypopyon uveitis in human immunodeficiency virus-negative immunocompetent individuals
- Bhagat N, Read RW, Rao NA, Smith RE, Chong LP. Rifabutin-associated hypopyon uveitis in human immunodeficiency virus-negative immunocompetent individuals. Ophthalmology 2001;108:750-2
- (2001) Ophthalmology , vol.108 , pp. 750-752
- Bhagat, N.¹ Read, R.W.² Rao, N.A.³ Smith, R.E.⁴ Chong, L.P.⁵

6
- 0028154815
- Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin
- Saran BR, Maguire AM, Nichols C, et al. Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin. Arch Ophthalmol 1994;112:1159-65
- (1994) Arch Ophthalmol , vol.112 , pp. 1159-1165
- Saran, B.R.¹ Maguire, A.M.² Nichols, C.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.